...
首页> 外文期刊>Biochemical and Biophysical Research Communications >An &ITFBXO40&IT knockout generated by CRISPR/Cas9 causes muscle hypertrophy in pigs without detectable pathological effects
【24h】

An &ITFBXO40&IT knockout generated by CRISPR/Cas9 causes muscle hypertrophy in pigs without detectable pathological effects

机译:AN&ITFBXO40和IT敲除CRISPR / CAS9产生的肌肉肥大在没有可检测的病理影响的情况下

获取原文
获取原文并翻译 | 示例
           

摘要

The regulatory function of Fbxo40 has been well characterized in mice. As a key component of the SCF-E3 ubiquitin ligase complex, Fbxo40 induces IRSI ubiquitination, thus inactivating the IGF1 /Akt pathway. The expression of Fbxo40 is restricted to muscle, and mice with an Fbxo40 null mutation exhibit muscle hypertrophy. However, the function of FBXO40 has not been elucidated in pigs, and it is not known whether FBXO40 mutations affect their health. We therefore generated FBXO40 knockout pigs using somatic cell nuclear transfer (SCNT) technology. CRISPR/Cas9 technology was combined with G418 selection, making it possible to generate donor cells at an efficiency of 75.86%. In muscle from FBXO40 knockout pigs, IRS1 levels were higher, and the IGFI/Akt pathway was stimulated. Mutant animals also had approximately 4% more muscle mass compared to WT controls. The knockout pigs developed normally and no pathological changes were found in major organs. These results demonstrate that FBXO40 is a promising candidate gene for improving production traits in agricultural livestock and for developing therapeutic interventions for muscle diseases. (C) 2018 Published by Elsevier Inc.
机译:FBXO40的监管功能在小鼠中表现出很好。作为SCF-E3泛素连接酶复合物的关键组分,FBXO40诱导IRSI泛素,从而灭活IGF1 / AKT途径。 FBXO40的表达仅限于肌肉,并且具有FBXO40禁突的小鼠表现出肌肉肥大。然而,FBXO40的功能尚未在猪中阐明,并不知道FBXO40突变是否影响其健康。因此,我们使用体细胞核转移(SCNT)技术产生FBXO40敲除猪。 CRISPR / CAS9技术与G418选择相结合,使得能够以75.86%的效率产生供体细胞。在FBXO40敲除猪的肌肉中,IRS1水平较高,刺激IGFI / AKT途径。与WT对照相比,突变动物也具有约4%的肌肉质量。敲除猪通常开发,主要在主要器官中没有发现病理变化。这些结果表明,FBXO40是一种有前途的候选基因,用于改善农业牲畜中的生产性状,并为肌肉疾病制定治疗干预措施。 (c)2018年由elsevier公司发布

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号